Impact of previous high-dose therapy on outcome after allografting for multiple myeloma

Keyphrases

• Multiple Myeloma 100%
• Marrow 100%
• High-dose Therapy 100%
• Allografting 100%
• Unrelated Donor 100%
• Renal Disease 33%
• Graft Failure 33%
• Overall Survival 33%
• Survivors 33%
• Disease Progression 33%
• Infection Rate 33%
• Myeloma 33%
• Living Donor 33%
• Graft-versus-host Disease (GvHD) 33%
• Young Patients 33%
• Disease-free Survival 33%
• Early Death 33%
• Allogeneic Bone Marrow Transplantation 33%
• Hepatic Dysfunction 33%
• Matched Sibling 33%
• Treatment-related Mortality 33%
• Single-center Experience 33%
• Haploidentical 33%

Medicine and Dentistry

• Drug Megadose 100%
• Multiple Myeloma 100%
• Disease Free Survival 50%
• Overall Survival 50%
• Allogenic Bone Marrow Transplantation 50%
• Disease Exacerbation 50%
• Myeloma 50%
• Graft Failure 50%
• Liver Dysfunction 50%
• Graft Versus Host Reaction 50%
• Diseases 50%

Immunology and Microbiology

• Drug Megadose 100%
• Multiple Myeloma 100%
• Graft-Versus-Host Disease 50%
• Allogeneic Bone Marrow Transplantation 50%
• Overall Survival 50%
• Disease Free Survival 50%